Tryptamine Therapeutics (Tryp) has announced the completion of subject dosing in a Phase Ib clinical trial of TRP-8803, for ...

The Phase I trial of the combination therapy saw a an approximate 66% rate of near-complete remission in its cohort of breast ...

Gilead Sciences has announced the outcomes from the Phase III PURPOSE 2 trial evaluating lenacapavir for HIV prevention.

As more companies are investigating radiopharmaceuticals, the complexities and red tape faced by sponsors are becoming more ...

Professor Rebecca Fitzgerald demonstrates the capsule sponge. Credit: StillVision. A pivotal investigator-led clinical trial for a new ‘pill-on-a-thread’ innovation for oesophageal cancer screening ...

The grant is set to enhance patient outcomes and quality of life for those with inflammatory bowel disease Credit: Peakstock/Shutterstock. Takeda Canada has co-sponsored the Canadian Inflammatory ...

As such, the demand for efficient lead generation in this niche is paramount. Companies and stakeholders in the clinical trials industry are increasingly seeking out leading providers and technology ...

As the first cohort of patients are dosed in the Phase II trial, multiple new trial sites are added for the glioblastoma ...

The results demonstrate the safety and efficacy of Fasenra in the treatment of acute eosinophilic exacerbations in asthma and ...

SELLAS has announced positive data from preclinical studies identifying the ASXL1 mutation as a predictor of response to ...